Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. (2nd January 2017) - Sashegyi, Andreas; Zhang, Yawei; Lin, Yong; Binder, Polina; Ferry, David